In vivo effects of 3,4-methylenedioxymethamphetamine (MDMA) and its deuterated form in rodents: Drug discrimination and thermoregulation.
Berquist, M. D., Leth-Petersen, S., Kristensen, J. L., & Fantegrossi, W. E. | Drug and Alcohol Dependence | 13 January 2020
Prospective examination of synthetic 5-methoxy-N,N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgment
Uthaug, M. V., Lancelotta, R., Szabo, A., Davis, A. K., Riba, J., & Ramaekers, J. G. | Psychopharmacology | 10 December 2019
Metabolism of lysergic acid diethylamide (LSD): an update.
Libânio Osório Marta, R. F. | Drug metabolism reviews | 16 July 2019
Spectral signatures of serotonergic psychedelics and glutamatergic dissociatives
Pallavicini, C., Vilas, M. G., Villarreal, M., Zamberlan, F., Muthukumaraswamy, S., Nutt, D., & Tagliazucchi, E. | NeuroImage | 24 June 2019
Pharmacokinetics and subjective effects of a novel oral LSD formulation in healthy subjects.
Holze, F., Duthaler, U., Vizeli, P., Müller, F., Borgwardt, S., & Liechti, M. E. | British journal of clinical pharmacology | 29 Apr 2019
Cytochrome P450 enzymes contribute to the metabolism of LSD to nor-LSD and 2-oxo-3-hydroxy-LSD: Implications for clinical LSD use
Luethi, D., Hoener, M. C., Krähenbühl, S., Liechti, M. E., & Duthaler, U. | Biochemical pharmacology | 11 April 2019